{"DataElement":{"publicId":"7736591","version":"1","preferredName":"Tumor Sample Description Indicator","preferredDefinition":"The indicator that describe if the sample was for the primary or recurrent tumor.","longName":"PRIMARY_OR_RECURRENT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"7736583","version":"1","preferredName":"Tumor Sample Description","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A written or verbal account, representation, statement, or explanation of something.","longName":"2480010v1.0:2222846v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2480010","version":"1","preferredName":"Neoplasm Specimen","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.:Specimen; a bit of tissue or blood or urine that is taken or used for research purposes.","longName":"C3262:C19157","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12BE1EFA-E1EA-6C8C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-01","endDate":null,"createdBy":"PWEST","dateCreated":"2006-05-01","modifiedBy":"ONEDATA","dateModified":"2006-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222846","version":"1","preferredName":"Description","preferredDefinition":"A statement or an account describing something.","longName":"C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211337-E099-4E34-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCG:Center for Cancer Genomics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F12D6A-EBD6-7CAB-E053-4EBD850A87AB","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"KUMMEROA","dateModified":"2021-07-21","changeDescription":"2021-7-12 ak Created for CCG HOPE-CARE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7736586","version":"1","preferredName":"Tumor Sample Description Indicator","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis._A written or verbal account, representation, statement, or explanation of something._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"TUMOR_SPECM_DESC_IND","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"15","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F168A1-5C0D-792F-E053-4EBD850AF584","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"Recurrent","valueDescription":"Recurrent Neoplasm Specimen","ValueMeaning":{"publicId":"7736587","version":"1","preferredName":"Recurrent Neoplasm Specimen","longName":"7736587","preferredDefinition":"The reemergence of a neoplasm after a period of remission.: A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent Neoplasm","conceptCode":"C4798","definition":"The reemergence of a neoplasm after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F168A1-5C1B-792F-E053-4EBD850AF584","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F168A1-5C34-792F-E053-4EBD850AF584","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"Primary","valueDescription":"Primary Neoplasm Specimen","ValueMeaning":{"publicId":"7736588","version":"1","preferredName":"Primary Neoplasm Specimen","longName":"7736588","preferredDefinition":"A tumor at the original site of origin.: A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F168A1-5C41-792F-E053-4EBD850AF584","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F168A1-5C5A-792F-E053-4EBD850AF584","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7736585","version":"1","preferredName":"Neoplasm Specimen Description Indicator","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.:A written or verbal account, representation, statement, or explanation of something.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C3262:C19157:C25365:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Specimen","conceptCode":"C19157","definition":"A part of a thing, or of several things, taken to demonstrate or to determine the character of the whole, e.g. a substance, or portion of material obtained for use in testing, examination, or study; particularly, a preparation of tissue or bodily fluid taken for examination or diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F168A1-5BE6-792F-E053-4EBD850AF584","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCG:Center for Cancer Genomics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F168A1-5BF7-792F-E053-4EBD850AF584","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"KUMMEROA","dateModified":"2021-07-21","changeDescription":"2021-7-12 ak Created for CCG HOPE-CARE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6705584","version":"1","longName":"CCG PTCL (Center for Cancer Genomics - Peripheral T Cell Lymphoma)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"7715738","version":"1","longName":"HOPE-CARE","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Was the sample for the primar","type":"Preferred Question Text","description":"Was the sample for the primary or recurrent tumor?","url":null,"context":"NCIP"}],"origin":"CCG:Center for Cancer Genomics","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F17C18-D706-5CE5-E053-4EBD850AB5E8","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-07-12","modifiedBy":"KUMMEROA","dateModified":"2021-07-21","changeDescription":"2021-7-12 ak Created for CCG HOPE-CARE.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}